Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Matching mice to malignancy: molecular subgroups and models of medulloblastoma.

Lau J, Schmidt C, Markant SL, Taylor MD, Wechsler-Reya RJ, Weiss WA.

Childs Nerv Syst. 2012 Apr;28(4):521-32. doi: 10.1007/s00381-012-1704-1. Review.

2.

SnapShot: Medulloblastoma.

Rusert JM, Wu X, Eberhart CG, Taylor MD, Wechsler-Reya RJ.

Cancer Cell. 2014 Dec 8;26(6):940-940.e1. doi: 10.1016/j.ccell.2014.11.015.

3.

Medulloblastoma: mouse models and novel targeted therapies based on the Sonic hedgehog pathway.

Piedimonte LR, Wailes IK, Weiner HL.

Neurosurg Focus. 2005 Nov 15;19(5):E8. Review.

PMID:
16398472
4.

Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology.

de Haas TG, Kool M.

Clin Neuropathol. 2007 May-Jun;26(3):93-110. Review.

PMID:
19157001
5.

Medulloblastoma: molecular genetics and animal models.

Raffel C.

Neoplasia. 2004 Jul-Aug;6(4):310-22. Review.

6.

Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease.

Ellison DW.

Acta Neuropathol. 2010 Sep;120(3):305-16. doi: 10.1007/s00401-010-0726-6. Epub 2010 Jul 23. Review.

PMID:
20652577
7.

Anaplasia and grading in medulloblastomas.

Eberhart CG, Burger PC.

Brain Pathol. 2003 Jul;13(3):376-85. Review.

PMID:
12946027
8.

Medulloblastoma biology in the post-genomic era.

Archer TC, Pomeroy SL.

Future Oncol. 2012 Dec;8(12):1597-604. doi: 10.2217/fon.12.151. Review.

9.

Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.

Binning MJ, Niazi T, Pedone CA, Lal B, Eberhart CG, Kim KJ, Laterra J, Fults DW.

Cancer Res. 2008 Oct 1;68(19):7838-45. doi: 10.1158/0008-5472.CAN-08-1899.

10.

Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.

Gottardo NG, Hansford JR, McGlade JP, Alvaro F, Ashley DM, Bailey S, Baker DL, Bourdeaut F, Cho YJ, Clay M, Clifford SC, Cohn RJ, Cole CH, Dallas PB, Downie P, Doz F, Ellison DW, Endersby R, Fisher PG, Hassall T, Heath JA, Hii HL, Jones DT, Junckerstorff R, Kellie S, Kool M, Kotecha RS, Lichter P, Laughton SJ, Lee S, McCowage G, Northcott PA, Olson JM, Packer RJ, Pfister SM, Pietsch T, Pizer B, Pomeroy SL, Remke M, Robinson GW, Rutkowski S, Schoep T, Shelat AA, Stewart CF, Sullivan M, Taylor MD, Wainwright B, Walwyn T, Weiss WA, Williamson D, Gajjar A.

Acta Neuropathol. 2014 Feb;127(2):189-201. doi: 10.1007/s00401-013-1213-7. Epub 2013 Nov 22.

11.

Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.

Polkinghorn WR, Tarbell NJ.

Nat Clin Pract Oncol. 2007 May;4(5):295-304. Review.

PMID:
17464337
12.

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.

Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J, Mrsić A, Ylstra B, Grajkowska W, Hartmann W, Pietsch T, Ellison D, Clifford SC, Versteeg R.

PLoS One. 2008 Aug 28;3(8):e3088. doi: 10.1371/journal.pone.0003088.

13.

Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.

Ellison DW, Kocak M, Dalton J, Megahed H, Lusher ME, Ryan SL, Zhao W, Nicholson SL, Taylor RE, Bailey S, Clifford SC.

J Clin Oncol. 2011 Apr 10;29(11):1400-7. doi: 10.1200/JCO.2010.30.2810. Epub 2010 Oct 4.

14.

Mouse models of medulloblastoma.

Wu X, Northcott PA, Croul S, Taylor MD.

Chin J Cancer. 2011 Jul;30(7):442-9. doi: 10.5732/cjc.011.10040. Review.

15.

Medulloblastoma: from molecular pathology to therapy.

Rossi A, Caracciolo V, Russo G, Reiss K, Giordano A.

Clin Cancer Res. 2008 Feb 15;14(4):971-6. doi: 10.1158/1078-0432.CCR-07-2072. Review.

16.

Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma.

Zhao X, Liu Z, Yu L, Zhang Y, Baxter P, Voicu H, Gurusiddappa S, Luan J, Su JM, Leung HC, Li XN.

Neuro Oncol. 2012 May;14(5):574-83. doi: 10.1093/neuonc/nos061. Epub 2012 Mar 29.

17.

A mouse model of the most aggressive subgroup of human medulloblastoma.

Kawauchi D, Robinson G, Uziel T, Gibson P, Rehg J, Gao C, Finkelstein D, Qu C, Pounds S, Ellison DW, Gilbertson RJ, Roussel MF.

Cancer Cell. 2012 Feb 14;21(2):168-80. doi: 10.1016/j.ccr.2011.12.023.

18.

Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma.

Gutova M, Shackleford GM, Khankaldyyan V, Herrmann KA, Shi XH, Mittelholtz K, Abramyants Y, Blanchard MS, Kim SU, Annala AJ, Najbauer J, Synold TW, D'Apuzzo M, Barish ME, Moats RA, Aboody KS.

Gene Ther. 2013 Feb;20(2):143-50. doi: 10.1038/gt.2012.12. Epub 2012 Mar 8.

19.

Isochromosome 17q, MYC amplification and large cell/anaplastic phenotype in a case of medullomyoblastoma with extracranial metastases.

Wright KD, von der Embse K, Coleman J, Patay Z, Ellison DW, Gajjar A.

Pediatr Blood Cancer. 2012 Sep;59(3):561-4. doi: 10.1002/pbc.24002. Epub 2011 Dec 6.

20.

Childhood medulloblastoma: the paradigm shift in molecular stratification and treatment profile.

Sadighi Z, Vats T, Khatua S.

J Child Neurol. 2012 Oct;27(10):1302-7. Epub 2012 Jul 22. Review.

PMID:
22826514
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk